Pulmonary hypertension in patients with idiopathic pulmonary fibrosis

Hassan F. Nadrous, Patricia Pellikka, Michael Joseph Krowka, Karen L. Swanson, Nithima Chaowalit, Paul A. Decker, Jay H Ryu

Research output: Contribution to journalArticle

275 Citations (Scopus)

Abstract

Study objectives: To determine the impact on survival and clinical correlates of pulmonary hypertension (PH) occurring in patients with idiopathic pulmonary fibrosis (IPF). Design: Retrospective study. Setting: Tertiary care, referral medical center. Patients: Among 487 consecutive patients with IPF, we identified 136 patients who underwent transthoracic echocardiography within 3 months of their initial evaluation at our institution. Patients with left ventricular dysfunction, valvular heart disease, incomplete follow-up, and those in whom pulmonary artery pressures could not be assessed were excluded; the remaining 88 patients were included in this study. Correlations were performed between echocardiographic measures of PH and clinical variables including survival. Measurements and results: The mean (± SD) estimated systolic pulmonary artery pressure (SPAP) for the 88 patients was 48 ± 16 mm Hg (range, 28 to 116 mm Hg). Among pulmonary function parameters, SPAP correlated best with diffusing capacity of the lung for carbon monoxide (DLCO), to which it was inversely related. For survival analysis, patients were stratified into three groups: ≤ 35 mm Hg (14 patients), 36 to 50 mm Hg (47 patients), and > 50 mm Hg (27 patients). Using the Kaplan-Meier method, the median survival rates for these three groups were 4.8 years, 4.1 years, and 0.7 years, respectively. Those patients with SPAP > 50 mm Hg had significantly worse survival compared to other subgroups (p = 0.009). Conclusion: In patients with IPF, PH correlates inversely with DLCO and has a significant adverse impact on survival, particularly when SPAP is > 50 mm Hg.

Original languageEnglish (US)
Pages (from-to)2393-2399
Number of pages7
JournalChest
Volume128
Issue number4
DOIs
StatePublished - Oct 2005

Fingerprint

Idiopathic Pulmonary Fibrosis
Pulmonary Hypertension
Pulmonary Artery
Pressure
Survival
Lung Volume Measurements
Heart Valve Diseases
Left Ventricular Dysfunction
Tertiary Healthcare
Carbon Monoxide
Survival Analysis
Echocardiography

Keywords

  • Echocardiography
  • Idiopathic pulmonary fibrosis
  • Prognosis
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. / Nadrous, Hassan F.; Pellikka, Patricia; Krowka, Michael Joseph; Swanson, Karen L.; Chaowalit, Nithima; Decker, Paul A.; Ryu, Jay H.

In: Chest, Vol. 128, No. 4, 10.2005, p. 2393-2399.

Research output: Contribution to journalArticle

Nadrous, Hassan F. ; Pellikka, Patricia ; Krowka, Michael Joseph ; Swanson, Karen L. ; Chaowalit, Nithima ; Decker, Paul A. ; Ryu, Jay H. / Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. In: Chest. 2005 ; Vol. 128, No. 4. pp. 2393-2399.
@article{965ec18215b244a4be4a291600ce6c43,
title = "Pulmonary hypertension in patients with idiopathic pulmonary fibrosis",
abstract = "Study objectives: To determine the impact on survival and clinical correlates of pulmonary hypertension (PH) occurring in patients with idiopathic pulmonary fibrosis (IPF). Design: Retrospective study. Setting: Tertiary care, referral medical center. Patients: Among 487 consecutive patients with IPF, we identified 136 patients who underwent transthoracic echocardiography within 3 months of their initial evaluation at our institution. Patients with left ventricular dysfunction, valvular heart disease, incomplete follow-up, and those in whom pulmonary artery pressures could not be assessed were excluded; the remaining 88 patients were included in this study. Correlations were performed between echocardiographic measures of PH and clinical variables including survival. Measurements and results: The mean (± SD) estimated systolic pulmonary artery pressure (SPAP) for the 88 patients was 48 ± 16 mm Hg (range, 28 to 116 mm Hg). Among pulmonary function parameters, SPAP correlated best with diffusing capacity of the lung for carbon monoxide (DLCO), to which it was inversely related. For survival analysis, patients were stratified into three groups: ≤ 35 mm Hg (14 patients), 36 to 50 mm Hg (47 patients), and > 50 mm Hg (27 patients). Using the Kaplan-Meier method, the median survival rates for these three groups were 4.8 years, 4.1 years, and 0.7 years, respectively. Those patients with SPAP > 50 mm Hg had significantly worse survival compared to other subgroups (p = 0.009). Conclusion: In patients with IPF, PH correlates inversely with DLCO and has a significant adverse impact on survival, particularly when SPAP is > 50 mm Hg.",
keywords = "Echocardiography, Idiopathic pulmonary fibrosis, Prognosis, Pulmonary hypertension",
author = "Nadrous, {Hassan F.} and Patricia Pellikka and Krowka, {Michael Joseph} and Swanson, {Karen L.} and Nithima Chaowalit and Decker, {Paul A.} and Ryu, {Jay H}",
year = "2005",
month = "10",
doi = "10.1378/chest.128.4.2393",
language = "English (US)",
volume = "128",
pages = "2393--2399",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4",

}

TY - JOUR

T1 - Pulmonary hypertension in patients with idiopathic pulmonary fibrosis

AU - Nadrous, Hassan F.

AU - Pellikka, Patricia

AU - Krowka, Michael Joseph

AU - Swanson, Karen L.

AU - Chaowalit, Nithima

AU - Decker, Paul A.

AU - Ryu, Jay H

PY - 2005/10

Y1 - 2005/10

N2 - Study objectives: To determine the impact on survival and clinical correlates of pulmonary hypertension (PH) occurring in patients with idiopathic pulmonary fibrosis (IPF). Design: Retrospective study. Setting: Tertiary care, referral medical center. Patients: Among 487 consecutive patients with IPF, we identified 136 patients who underwent transthoracic echocardiography within 3 months of their initial evaluation at our institution. Patients with left ventricular dysfunction, valvular heart disease, incomplete follow-up, and those in whom pulmonary artery pressures could not be assessed were excluded; the remaining 88 patients were included in this study. Correlations were performed between echocardiographic measures of PH and clinical variables including survival. Measurements and results: The mean (± SD) estimated systolic pulmonary artery pressure (SPAP) for the 88 patients was 48 ± 16 mm Hg (range, 28 to 116 mm Hg). Among pulmonary function parameters, SPAP correlated best with diffusing capacity of the lung for carbon monoxide (DLCO), to which it was inversely related. For survival analysis, patients were stratified into three groups: ≤ 35 mm Hg (14 patients), 36 to 50 mm Hg (47 patients), and > 50 mm Hg (27 patients). Using the Kaplan-Meier method, the median survival rates for these three groups were 4.8 years, 4.1 years, and 0.7 years, respectively. Those patients with SPAP > 50 mm Hg had significantly worse survival compared to other subgroups (p = 0.009). Conclusion: In patients with IPF, PH correlates inversely with DLCO and has a significant adverse impact on survival, particularly when SPAP is > 50 mm Hg.

AB - Study objectives: To determine the impact on survival and clinical correlates of pulmonary hypertension (PH) occurring in patients with idiopathic pulmonary fibrosis (IPF). Design: Retrospective study. Setting: Tertiary care, referral medical center. Patients: Among 487 consecutive patients with IPF, we identified 136 patients who underwent transthoracic echocardiography within 3 months of their initial evaluation at our institution. Patients with left ventricular dysfunction, valvular heart disease, incomplete follow-up, and those in whom pulmonary artery pressures could not be assessed were excluded; the remaining 88 patients were included in this study. Correlations were performed between echocardiographic measures of PH and clinical variables including survival. Measurements and results: The mean (± SD) estimated systolic pulmonary artery pressure (SPAP) for the 88 patients was 48 ± 16 mm Hg (range, 28 to 116 mm Hg). Among pulmonary function parameters, SPAP correlated best with diffusing capacity of the lung for carbon monoxide (DLCO), to which it was inversely related. For survival analysis, patients were stratified into three groups: ≤ 35 mm Hg (14 patients), 36 to 50 mm Hg (47 patients), and > 50 mm Hg (27 patients). Using the Kaplan-Meier method, the median survival rates for these three groups were 4.8 years, 4.1 years, and 0.7 years, respectively. Those patients with SPAP > 50 mm Hg had significantly worse survival compared to other subgroups (p = 0.009). Conclusion: In patients with IPF, PH correlates inversely with DLCO and has a significant adverse impact on survival, particularly when SPAP is > 50 mm Hg.

KW - Echocardiography

KW - Idiopathic pulmonary fibrosis

KW - Prognosis

KW - Pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=27144547143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144547143&partnerID=8YFLogxK

U2 - 10.1378/chest.128.4.2393

DO - 10.1378/chest.128.4.2393

M3 - Article

VL - 128

SP - 2393

EP - 2399

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4

ER -